Department of Hypertension, Institute of Cardiology, Warsaw, Poland
2nd Department of Radiology, Medical University of Warsaw, Warsaw, Poland
Pol Arch Intern Med. 2019 Apr 30;129(4):234-241. doi: 10.20452/pamw.4479. Epub 2019 Mar 7.
INTRODUCTION Data on the assessment of intrarenal blood flow parameters in patients with renal fibromuscular dysplasia (FMD) are scarce. OBJECTIVES The aim of the study was to evaluate intrarenal blood flow parameters in patients with FMD and significant or nonsignificant renal artery stenosis (RAS). PATIENTS AND METHODS We evaluated intrarenal blood flow parameters by Doppler ultrasonography in 153 patients with renal FMD enrolled in the ARCADIA‑POL study: 32 and 121 patients with and without significant RAS, respectively, compared with 60 matched patients with essential hypertension and 60 healthy controls. RESULTS Patients with FMD and significant RAS had a lower renal resistive index (RRI) compared with patients with FMD without significant RAS, patients with essential hypertension, and normotensive controls (mean [SD], 0.51 [0.08] vs 0.60 [0.07], 0.62 [0.06], and 0.61 [0.06], respectively; P <0.001). In patients with nonsignificant RAS, RRI correlated significantly with carotid intima-media thickness, 24‑hour diastolic blood pressure, 24‑hour pulse pressure, left ventricular diastolic function, known duration time of hypertension, and age. In patients with significant RAS, there was a significant correlation between RRI and known duration time of hypertension, left ventricular diastolic function, and age. In a separate, "per‑kidney" analysis, renal arteries with FMD and significant RAS were characterized by lower RRI values, higher maximal blood flow velocity, higher renal aortic ratio, and longer acceleration time compared with renal arteries with FMD and nonsignificant RAS as well as renal arteries without FMD. CONCLUSIONS In contrast to atherosclerotic RAS, intrarenal blood flow in patients with FMD and RAS is preserved, confirming that renal vasculature is relatively intact in these patients.
关于肾血管平滑肌脂肪瘤(FMD)患者肾内血流参数评估的数据很少。
本研究旨在评估 FMD 伴或不伴显著肾动脉狭窄(RAS)患者的肾内血流参数。
我们通过多普勒超声评估了 ARCADIA-POL 研究中的 153 例 FMD 患者的肾内血流参数:32 例和 121 例患者分别伴有和不伴有显著 RAS,并与 60 例原发性高血压患者和 60 例健康对照者进行了比较。
与不伴有显著 RAS 的 FMD 患者、原发性高血压患者和血压正常的对照组相比,伴有显著 RAS 的 FMD 患者的肾阻力指数(RRI)较低(均值[标准差]:0.51[0.08] vs. 0.60[0.07]、0.62[0.06]和 0.61[0.06];P<0.001)。在不伴有显著 RAS 的患者中,RRI 与颈动脉内膜中层厚度、24 小时舒张压、24 小时脉压、左心室舒张功能、已知高血压持续时间和年龄显著相关。在伴有显著 RAS 的患者中,RRI 与已知高血压持续时间、左心室舒张功能和年龄之间存在显著相关性。在单独的“每肾”分析中,与肾内 FMD 和不伴显著 RAS 的肾动脉以及无 FMD 的肾动脉相比,伴有 FMD 和显著 RAS 的肾动脉的 RRI 值较低、最大血流速度较高、肾主动脉比值较高、加速时间较长。
与动脉粥样硬化性 RAS 相反,FMD 伴 RAS 的患者肾内血流得以保留,这证实了这些患者的肾血管相对完整。